Healthcare -
Biotechnology - NASDAQ - GB
$ 0.3
-0.892 %
$ 76.8 M
Market Cap
-1.0
P/E
ADAP - REVENUE
Revenue ADAP - Adaptimmune Therapeutics plc
178 M
LAST VALUE
156.08%
2 YEAR CAGR
175.49%
5 YEAR CAGR
76.56%
10 YEAR CAGR